Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
448.15
381.30
458.18
628.17
676.57
554.87
522.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
448.15
381.30
458.18
628.17
676.57
554.87
522.61
Raw Material Cost
270.45
248.86
318.82
460.83
444.82
344.60
333.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.37
(Increase) / Decrease In Stocks
27.96
48.08
0.46
-59.59
-58.00
-2.55
4.73
Employee Cost
62.91
61.10
61.74
52.26
50.31
38.35
29.92
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
91.35
89.47
83.08
98.41
85.37
62.91
68.98
Total Expenditure (Excl Depreciation)
452.67
447.51
464.10
551.91
522.49
443.31
437.43
Operating Profit (PBDIT) excl Other Income
-4.52
-66.21
-5.92
76.26
154.08
111.56
85.18
Other Income
5.07
5.63
5.64
13.06
10.47
7.92
11.93
Operating Profit (PBDIT)
0.55
-60.58
-0.28
89.32
164.55
119.48
97.11
Interest
34.53
36.70
25.23
20.71
9.06
4.75
12.59
Exceptional Items
-2.09
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-36.07
-97.28
-25.51
68.61
155.49
114.73
84.52
Depreciation
44.92
43.71
36.25
33.65
34.36
25.66
23.16
Profit Before Tax
-81.00
-140.99
-61.75
34.95
121.13
89.07
61.35
Tax
-0.12
-6.28
-14.86
9.35
31.24
24.00
13.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-80.88
-134.71
-46.89
25.59
89.88
65.07
47.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-80.88
-134.71
-46.89
25.59
89.88
65.07
47.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.04
-0.04
-0.04
-0.03
-0.02
-0.02
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-80.92
-134.75
-46.93
25.56
89.86
65.05
47.51
Equity Capital
22.28
19.61
19.61
19.61
19.59
19.59
19.57
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
215.13
349.68
399.76
376.90
289.59
227.00
Earnings per share (EPS)
-36.32
-68.22
-23.76
13.03
45.87
33.21
24.28
Diluted Earnings per share
-37.79
-68.21
-23.76
13.04
45.85
33.21
24.27
Operating Profit Margin (Excl OI)
-1.01%
-17.36%
-1.29%
12.14%
22.77%
20.11%
16.3%
Gross Profit Margin
-8.05%
-25.51%
-5.57%
10.92%
22.98%
20.68%
16.17%
PAT Margin
-18.05%
-35.33%
-10.23%
4.07%
13.28%
11.73%
9.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.53% vs -16.78% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 39.95% vs -187.13% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 93.17% vs -1,018.41% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -5.91% vs 45.46% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Astec Lifescienc With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
448.15
828.60
-380.45
-45.91%
Other Operating Income
0.00
0.00
0.00
Total Operating income
448.15
828.60
-380.45
-45.91%
Raw Material Cost
270.45
474.29
-203.84
-42.98%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
27.96
-15.50
43.46
280.39%
Employee Cost
62.91
53.27
9.64
18.10%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
91.35
196.98
-105.63
-53.62%
Total Expenditure (Excl Depreciation)
452.67
709.04
-256.37
-36.16%
Operating Profit (PBDIT) excl Other Income
-4.52
119.56
-124.08
-103.78%
Other Income
5.07
14.83
-9.76
-65.81%
Operating Profit (PBDIT)
0.55
134.39
-133.84
-99.59%
Interest
34.53
4.84
29.69
613.43%
Exceptional Items
-2.09
0.00
-2.09
Gross Profit (PBDT)
-36.07
129.55
-165.62
-127.84%
Depreciation
44.92
18.19
26.73
146.95%
Profit Before Tax
-81.00
111.36
-192.36
-172.74%
Tax
-0.12
29.18
-29.30
-100.41%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-80.88
82.18
-163.06
-198.42%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-80.88
82.18
-163.06
-198.42%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.04
0.00
-0.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-80.92
82.18
-163.10
-198.47%
Equity Capital
22.28
11.52
10.76
93.40%
Face Value
10.00
1.00
0.00
Reserves
0.00
886.89
-886.89
-100.00%
Earnings per share (EPS)
-36.32
7.13
-43.45
-609.40%
Diluted Earnings per share
-37.79
7.14
-44.93
-629.27%
Operating Profit Margin (Excl OI)
-1.01%
14.43%
0.00
-15.44%
Gross Profit Margin
-8.05%
15.63%
0.00
-23.68%
PAT Margin
-18.05%
9.92%
0.00
-27.97%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 448.15 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.53% vs -16.78% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit -80.92 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 39.95% vs -187.13% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -4.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 93.17% vs -1,018.41% in Mar 2025
Annual - Interest
Interest 34.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -5.91% vs 45.46% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.01%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






